CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
Expiratory Muscle Strength Training (EMST-150)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05003167
NCT05003167N/ACompleted
CompareCT.gov

Effectiveness of Expiratory Muscle Strength Training for Improving Communication in ALS

Purdue University·interventional·Posted Aug 12, 2021·Updated Jun 8, 2023

In Brief

A clinical study evaluating Expiratory Muscle Strength Training (EMST-150) for Amyotrophic Lateral Sclerosis. Completed, enrolled 13 participants across 1 site.

Detailed Summary

A tele-health treatment study for individuals with early stage ALS with the aim to improve communication, cough response, and respiratory strength. All participants complete a respiratory strength training program using an Expiratory Muscle Strength Training (EMST 150) device from the comfort of their homes for 6 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmyotrophic Lateral Sclerosis
CountriesUnited States
CollaboratorsNational Institute on Deafness and Other Communication Disorders (NIDCD)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 12, 2021
Enrollment StartJan 1, 2021
Primary CompletionJun 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 4.9 years ago

Interventions

Expiratory Muscle Strength Training (EMST-150)device

All participants will forcefully breathe out into an Expiratory Muscle Strength Training device (EMST-150) 25 times per day for 6 weeks. The EMST device will be set at a moderate intensity level (50% of each participant's maximum expiratory pressure).